Поисковый запрос: (<.>A=Nakshatri, Harikrishna$<.>) |
Общее количество найденных документов : 23
Показаны документы с 1 по 20
|
|
1.
| Isolation of retinoic acid-repressed genes from P19 embryonal carcinoma cells // Gene, 1996. Vol. 174, N 1.-С.79-84
|
2.
| Isolation of retinoic acid-repressed genes from P19 embryonal carcinoma cells // Gene, 1996. Vol. 174, N 1.-С.79-84
|
3.
| Constitutive activation of NF-kB during progression of breast cancer to hormone-independent growth // Mol. and Cell. Biol., 1997. Vol. 17, N 7.-С.3629-3639
|
4.
| NF-'каппа'B activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1'альфа' // Proc. Nat. Acad. Sci. USA, 1998. Vol. 95, N 12.-С.6971-6976
|
5.
| NF-'каппа'B activation and interleukin 6 production in fibroblasts by estrogen receptor-negative breast cancer cell-derived interleukin 1'альфа' // Proc. Nat. Acad. Sci. USA, 1998. Vol. 95, N 12.-С.6971-6976
|
6.
| Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells // Biochem. and Biophys. Res. Commun., 1999. Vol. 255, N 3.-С.703-706
|
7.
| Negative regulation of transactivation function but not DNA binding of NF-'каппа'B and AP-1 by I'каппа'B'бета'1 in breast cancer cells // J. Biol. Chem., 1999. Vol. 274, N 26.-С.18827-18835
|
8.
| Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer // Invest. New Drugs, 2004. Vol. 22, N 3.-С.299-305
|
9.
| Phase I dose escalation trial of feverfew with standardized doses of parthenolide in patients with cancer // Invest. New Drugs, 2004. Vol. 22, N 3.-С.299-305
|
10.
| Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model // Prostate, 2006. Vol. 66, N 14.-С.1498-1511
|
11.
| Restoring chemotherapy and hormone therapy sensitivity by parthenolide in a xenograft hormone refractory prostate cancer model // Prostate, 2006. Vol. 66, N 14.-С.1498-1511
|
12.
| A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-kB and generating reactive oxygen species // Int. J. Cancer, 2011. Vol. 128, N 10.-С.2481-2494
|
13.
| A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-kB and generating reactive oxygen species // Int. J. Cancer, 2011. Vol. 128, N 10.-С.2481-2494
|
14.
| A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-kB and generating reactive oxygen species // Int. J. Cancer, 2011. Vol. 128, N 10.-С.2481-2494
|
15.
| A water soluble parthenolide analog suppresses in vivo tumor growth of two tobacco-associated cancers, lung and bladder cancer, by targeting NF-kB and generating reactive oxygen species // Int. J. Cancer, 2011. Vol. 128, N 10.-С.2481-2494
|
16.
| Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain // J. Pathol., 2014. Vol. 232, N 3.-С.369-381
|
17.
| Angiopoietin-2 mediates blood-brain barrier impairment and colonization of triple-negative breast cancer cells in brain // J. Pathol., 2014. Vol. 232, N 3.-С.369-381
|
18.
| Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA // Nature, 1988. Vol. 335, N 6193.-С.832-835
|
19.
| Nakshatri Functional role of BK virus tumor antigens in transformation // J. Virol., 1988. Vol. 62, N 12.-С.4613-4621
|
20.
| Glucocorticoid-dependent oncogenic transformation by type 16 but not type 11 human papilloma virus DNA // Nature, 1988. Vol. 335, N 6193.-С.832-835
|
&uf('+1W2226#',v2226), ?>
|
|